Emergex Vaccines
-
Emergex Vaccines expands at Milton Park
Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats has expanded at Milton Park.
Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats has expanded at Milton Park.